Antibody Responses in Pediatric Dengue Indicate Emergence and Co‐Circulation of DENV‐3 Genotypes I and III in Myanmar and Orthoflavivirus Cross‐Reactivity
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.71079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Jean Claude Balingit und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki City, Nagasaki, Japan. Hauptthemen laut MEDLINE: Genotype, Antibodies, Viral, Dengue, Dengue Virus. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development (AMED), Japan Society for the Promotion of Sciences (JSPS).
Abstract (Originalsprache)
Dengue virus (DENV) remains a major public health concern in Southeast Asia, disproportionately affecting children. In Myanmar, DENV‐3 Genotype III predominated before 2017, with Genotype I emerging thereafter. To assess the impact of this emergence on antibody responses, we analyzed paired acute and convalescent serum samples from 38 pediatric dengue patients collected between 2017 and 2019 alongside archived 2004 samples. Neutralization and in vitro antibody‐dependent enhancement (ADE) were assessed against DENV‐3 Genotypes I and III and other serotypes, with cross‐reactivity analysis to Zika and Japanese encephalitis viruses. Samples from 2004 showed reduced neutralization and higher ADE for Genotype I, consistent with its absence at the time. In contrast, 2017–2019 samples exhibited comparable neutralization for both genotypes, with genotype‐ and year‐dependent ADE differences, indicating that Genotype I emergence was associated with evolving functional antibody profiles. Hence, providing immunological evidence for continued co‐circulation of DENV‐3 Genotypes I and III in Myanmar. Future prospective pediatric cohort studies with continuous surveillance of circulating orthoflaviviruses and their genotypes, are essential to elucidate how pre‐existing dengue immunity shapes genotype emergence and cross‐orthoflavivirus immunity in endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University, Nagasaki City, Nagasaki, Japan.
- Department of Medical Research, Yangon, Myanmar.
- Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama City, Tokyo, Japan.
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki City, Nagasaki, Japan.
- Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo City, Japan.
- Myanmar Academy of Medical Science, Yangon, Myanmar.
ORCID-Profile: Mya Myat Ngwe Tun
Förderung
- Japan Agency for Medical Research and Development (AMED)
- Japan Society for the Promotion of Sciences (JSPS)
Zitieren
APA
Balingit, J. C., Nwe, K. M., Lin, H., Aung, W. W., Suzuki, R., Takamatsu, Y., Urano, T., Khin, A. A., Thant, K. Z., Thu, H. M., Ngwe Tun, M. M., & Morita, K. (2026). Antibody Responses in Pediatric Dengue Indicate Emergence and Co‐Circulation of DENV‐3 Genotypes I and III in Myanmar and Orthoflavivirus Cross‐Reactivity. Journal of Medical Virology. https://doi.org/10.1002/jmv.71079
Vancouver
Balingit JC, Nwe KM, Lin H, Aung WW, Suzuki R, Takamatsu Y, et al. Antibody Responses in Pediatric Dengue Indicate Emergence and Co‐Circulation of DENV‐3 Genotypes I and III in Myanmar and Orthoflavivirus Cross‐Reactivity. Journal of Medical Virology. 2026. doi:10.1002/jmv.71079
BibTeX
@article{Balingit2026,
author = {Balingit, Jean Claude and Nwe, Khine Mya and Lin, Htin and Aung, Wah Wah and Suzuki, Ryosuke and Takamatsu, Yuki and Urano, Takeshi and Khin, Aye Aye and Thant, Kyaw Zin and Thu, Hlaing Myat and Ngwe Tun, Mya Myat and Morita, Kouichi},
title = {Antibody Responses in Pediatric Dengue Indicate Emergence and Co‐Circulation of DENV‐3 Genotypes I and III in Myanmar and Orthoflavivirus Cross‐Reactivity},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.71079}
}
EUVIMED